31 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
LN LINE Corporation $41.2 $9.89B Downtrend
Article Searches
Line's (LN) CEO Takeshi Idezawa on Q4 2017 Results - Earnings Call Transcript https://seekingalpha.com/article/4141938-lines-ln-ceo-takeshi-idezawa-q4-2017-results-earnings-call-transcript?source=feed_all_articles Jan 31, 2018 - Line Corp (ADR) (NASDAQ:LN) Q4 2017 Earnings Conference Call January 31, 2018 3:00 AM ET Executives Takeshi Idezawa – Chief Executive Officer In Joon Hwang – Chief Financial Officer Analysts Yoshitaka
Better Stock: Twilio (TWLO) vs. Line Corp. (LN) https://www.fool.com/investing/2017/12/18/better-stock-twilio-twlo-vs-line-corp-ln.aspx?source=iedfolrf0000001 Dec 18, 2017 - Which tech IPO from 2016 will fare better in 2018 and beyond?
Should LINE Corporation (LN) Be On Your Radar Now? http://www.zacks.com/stock/news/285781/should-line-corporation-ln-be-on-your-radar-now?cid=CS-ZC--285781 Dec 13, 2017 - LINE Corporation (LN) sees solid earnings estimate revisions and looks poised to shock the market, and yet seems overlooked by the investors.
LINE's (LN) CEO Takeshi Idezawa on Q3 2017 Results - Earnings Call Transcript https://seekingalpha.com/article/4118214-lines-ln-ceo-takeshi-idezawa-q3-2017-results-earnings-call-transcript?source=feed_all_articles Oct 30, 2017 - LINE Corporation (NASDAQ:LN) Q3 2017 Earnings Conference Call October 25, 2017 04:00 AM ET Executives Satoshi Yano - ‎Head of Marketing Communication Department Takeshi Idezawa - President and Chief E
Why LINE Corp. Shares Jumped 16% Today https://www.fool.com/investing/2017/10/25/why-line-corp-shares-jumped-16-today.aspx?source=iedfolrf0000001 Oct 25, 2017 - The Far Eastern social network maven reported solid Q3 results and indicated good tidings ahead for key markets such as Thailand, Japan, and Taiwan.
Iovance Biotherapeutics +13% on FDA fast track designation for LN-144 https://seekingalpha.com/news/3293097-iovance-biotherapeutics-plus-13-percent-fda-fast-track-designation-lnminus-144?source=feed_news_all Aug 31, 2017 - Iovance Biotherapeutics (NASDAQ:IOVA) +13.1% AH after saying the FDA had granted fast track designation for LN-144, the company's lead product. LN-144 is an adoptive cell therapy using tumor-infiltra
Don't Be Misled by Lofty IPOs https://www.fool.com/investing/2017/07/19/dont-be-misled-by-lofty-ipos.aspx?source=iedfolrf0000001 Jul 19, 2017 - Tech IPOs have a reputation for ballooning their first few days of trading, but it doesn't take long for those valuations to cool down significantly.
Better Buy: Twilio Inc vs. Line Corp https://www.fool.com/investing/2017/07/05/better-buy-twilio-inc-vs-line-corp.aspx?source=iedfolrf0000001 Jul 06, 2017 - Will two of the biggest tech IPOs from 2016 finally impress investors this year?
Better Buy: Facebook, Inc. vs. Line Corp https://www.fool.com/investing/2017/06/18/better-buy-facebook-inc-vs-line-corp.aspx?source=iedfolrf0000001 Jun 18, 2017 - Which social networking stock is the better long-term play?
Aurinia's voclosporin shows durable response in mid-stage LN study; shares ahead 5% premarket https://seekingalpha.com/news/3273987-aurinias-voclosporin-shows-durable-response-mid-stage-ln-study-shares-ahead-5-percent?source=feed_news_all Jun 16, 2017 - Aurinia Pharmaceuticals (NASDAQ:AUPH) is up 5% premarket on average volume in response to its announcement of results from its Phase 2b AURA-LV study assessing voclosporin for the treatment

Pages: 1234

<Page 2>